| . "Statistical aspect of translational and correlative studies in clinical trials.." Chin Clin Oncol. 2016;5(1):11. Pub Med |
| . "Ten-year experience with extended criteria cardiac transplantation.." Circ Heart Fail. 2013;6(6):1230-8. Pub Med |
| . "Statistical considerations for analysis of microarray experiments.." Clin Transl Sci. 2011;4(6):466-77. Pub Med |
| . "I-Boost: An integrative boosting approach for predicting survival time with multiple genomics platforms.." Genome Biol. 2019;20(1):52. Pub Med |
| . "Clinical prognostic model for older patients with advanced non-small cell lung cancer.." J Geriatr Oncol. 2019;10(4):555-559. Pub Med |
| . "Time course and prognostic value of serum GFAP, pNFH, and S100β concentrations in dogs with complete spinal cord injury because of intervertebral disc extrusion.." J Vet Intern Med. 2019;33(2):726-734. Pub Med |
| . "Quantifying the average of the time-varying hazard ratio via a class of transformations.." Lifetime Data Anal. 2015;21(2):259-79. Pub Med |
| . "Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups.." Lung Cancer. 2015;90(2):281-7. Pub Med |
| . "Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer.." Lung Cancer. 2020;141():14-20. Pub Med |
| . "Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy.." Nat Commun. 2020;11(1):6410. Pub Med |
| . "CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method.." Comput Methods Programs Biomed. 2019;176():211-223. Pub Med |
| . "Tximeta: Reference sequence checksums for provenance identification in RNA-seq.." PLoS Comput Biol. 2020;16(2):e1007664. Pub Med |
| . "Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia.." Ann Oncol. 2019;30(4):542-550. Pub Med |
| . "Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: Exploratory analysis of the REMAGUS02 trial.." J Clin Oncol. 2019;37(8):624-635. Pub Med |
| . "K-Sample comparisons using propensity analysis.." Biom J. 2019;61(3):698-713. Pub Med |
| . "Reporting and guidelines in propensity score analysis: A systematic review of cancer and cancer surgical studies.." J Natl Cancer Inst. 2017;109(8):. Pub Med |
| . "On variance estimate for covariate adjustment by propensity score analysis.." Stat Med. 2016;35(20):3537-48. Pub Med |
| . "Subgroup detection and sample size calculation with proportional hazards regression for survival data.." Stat Med. 2017;36(29):4646-4659. Pub Med |
| . "Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).." Am Heart J. 2013;165(2):193-9. Pub Med |
| . "Efficient semiparametric estimation of short-term and long-term hazard ratios with right-censored data.." Biometrics. 2013;69(4):840-9. Pub Med |
| . "FLCRM: Functional linear Cox regression model.." Biometrics. 2018;74(1):109-117. Pub Med |
| . "Proportional hazards model with a change point for clustered event data.." Biometrics. 2017;73(3):835-845. Pub Med |
| . "Estimating effect of environmental contaminants on women's subfecundity for the MoBa study data with an outcome-dependent sampling scheme.." Biostatistics. 2014;15(4):636-50. Pub Med |
| . "Checking semiparametric transformation models with censored data.." Biostatistics. 2012;13(1):18-31. Pub Med |
| . "Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial.." Biostatistics. 2011;12(2):258-69. Pub Med |
| . "Marginal additive hazards model for case-cohort studies with multiple disease outcomes: an application to the Atherosclerosis Risk in Communities (ARIC) study.." Biostatistics. 2013;14(1):28-41. Pub Med |
| . "Prediction of a time-to-event trait using genome wide SNP data.." BMC Bioinformatics. 2013;14():58. Pub Med |
| . "Bayesian methods in clinical trials: A Bayesian analysis of ECOG trials E1684 and E1690.." BMC Med Res Methodol. 2012;12():183. Pub Med |
| . "Onset of persistent pseudomonas aeruginosa infection in children with cystic fibrosis with interval censored data.." BMC Med Res Methodol. 2016;16(1):122. Pub Med |
| . "Ten-year experience with extended criteria cardiac transplantation.." Circ Heart Fail. 2013;6(6):1230-8. Pub Med |
| . "Sample size considerations of prediction-validation methods in high-dimensional data for survival outcomes.." Genet Epidemiol. 2013;37(3):276-82. Pub Med |
| . "Power and sample size calculations for SNP association studies with censored time-to-event outcomes.." Genet Epidemiol. 2012;36(6):538-48. Pub Med |
| . "Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.." J Biopharm Stat. 2016;26(2):269-79. Pub Med |
| . "On sample size calculation for comparing survival curves under general hypothesis testing.." J Biopharm Stat. 2012;22(3):485-95. Pub Med |
| . "Statistical methods for conditional survival analysis. ." J Biopharm Stat. 2018;28(5):927-938. Pub Med |
| . "Basic concepts and methods for joint models of longitudinal and survival data.." J Clin Oncol. 2010;28(16):2796-801. Pub Med |
| . "Clinical prognostic model for older patients with advanced non-small cell lung cancer.." J Geriatr Oncol. 2019;10(4):555-559. Pub Med |
| . "Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.." J Natl Cancer Inst. 2012;104(3):211-27. Pub Med |
| . "Proportional exponentiated link transformed hazards (ELTH) models for discrete time survival data with application.." Lifetime Data Anal. 2016;22(1):38-62. Pub Med |
| . "Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed.." Lifetime Data Anal. 2013;19(4):513-46. Pub Med |
| . "A regularized variable selection procedure in additive hazards model with stratified case-cohort design.." Lifetime Data Anal. 2018;24(3):443-463. Pub Med |
| . "Joint modeling of survival time and longitudinal outcomes with flexible random effects.." Lifetime Data Anal. 2018;24(1):126-152. Pub Med |
| . "Quantifying the average of the time-varying hazard ratio via a class of transformations.." Lifetime Data Anal. 2015;21(2):259-79. Pub Med |
| . "Reweighted estimators for additive hazard model with censoring indicators missing at random.." Lifetime Data Anal. 2018;24(2):224-249. Pub Med |
| . "Pattern mixture models for clinical validation of biomarkers in the presence of missing data.." Stat Med. 2017;36(19):2994-3004. Pub Med |
| . "A global logrank test for adaptive treatment strategies based on observational studies.." Stat Med. 2014;33(5):760-71. Pub Med |
| . "Joint modeling of longitudinal and survival data with missing and left-censored time-varying covariates.." Stat Med. 2014;33(26):4560-76. Pub Med |
| . "Sample size calculation for studies with grouped survival data.." Stat Med. 2018;37(27):3904-3917. Pub Med |
| . "Subgroup detection and sample size calculation with proportional hazards regression for survival data.." Stat Med. 2017;36(29):4646-4659. Pub Med |
| . "Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group.." Stat Med. 2015;34(14):2181-95. Pub Med |
